Korean J Gastrointest Endosc.  2010 Nov;41(5):290-293.

Portal and Mesenteric Venous Thrombosis Complicating Endoscopic Injection Sclerotherapy

Affiliations
  • 1Department of Internal Medicine, Seoul Medical Center, Seoul, Korea. kbr207@dreamwiz.com
  • 2Department of Pathology, Seoul Medical Center, Seoul, Korea.

Abstract

Endoscopic injection sclerotherapy is an effective and relatively safe modality for controlling bleeding esophageal varices. Injection of sclerosant causes acute mural thrombosis with a necroinflammatory response and subsequent sclerosis in the venous system of the distal esophagus. A few cases of mesenteric venous thrombosis with small bowel infarction after sclerotherapy have been reported, and most of which were fatal. The association between mesenteric venous thrombosis and sclerotherapy has been strongly suggested, but this still remains unproved. We report here on a case of mesenteric venous thrombosis with small bowel infarction that developed after endoscopic injection sclerotherapy.

Keyword

Endoscopic injection sclerotherapy; Mesenteric venous thrombosis

MeSH Terms

Esophageal and Gastric Varices
Esophagus
Hemorrhage
Infarction
Sclerosis
Sclerotherapy
Thrombosis
Venous Thrombosis
Full Text Links
  • KJGE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr